SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Genstruct Applying Epistemics Approach To 'Molecular World' (BioWorld Today)
News | 01. 20. 2004
Genstruct Inc. is approaching a drug discovery obstacle in a thoroughly modern way, that is, with what it calls “logical models” of biological systems designed to uncover and define compound mechanisms of action and disease mechanisms.
